Feb 5 • 16:25 UTC 🇩🇪 Germany Die Welt

Eli Lilly or Novo Nordisk? The stock market has mercilessly decided

The market for weight-loss injections is expanding, but investors have decisively favored one pharmaceutical giant over the other.

📡 Similar Coverage